With the help of the PRIMA device, 80% of the 32 patients who returned for a reassessment one year after the chip implantation had achieved clinically meaningful visual improvements.

Blind patients can read and recognise faces again with a “revolutionary bionic chip” that is said to signal a “new era” for artificial vision.